DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

RSNA Product Showcase Some of the latest technology being showcased on the exhibit floor

The first (and only) female Medal of Honor winner How a doctor turned Civil War spy left her mark in history

Shanghai Pharma to acquire Cardinal Health China business for $1.2 billion Deal includes pharma and medical products distribution business

Carestream Health now shipping MyVue Center Self-Service Kiosk Provides patients with access to imaging exam records quicker

ARUP and ASI launch PathFusion pathology imaging suite Result of multi-year collaboration

Digital health intelligence finds the patient Innovation across the globe becomes increasingly mobile, digital, personal and accessible

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Sectra partners with Telemedicine Clinic to support orthopedic customers Offers teleradiology services for assessing loose implants

MEVION S250i Proton Therapy System scores CE mark First European installation to be in Netherlands

Philips' Azurion image-guided therapy speeds up treatment Can yield 17 percent reduction in interventional procedure time: study

Hologic wraps up $3.8 billion Gen-Probe buy

by Brendon Nafziger , DOTmed News Associate Editor
Hologic said Wednesday that it wrapped up its nearly $3.8 billion cash purchase of molecular diagnostics company Gen-Probe Inc., in line with the company's earlier projections.

On an earnings call this week, the publicly traded women's health medical device company indicated that it expected the deal, first announced in April, to finish by Aug. 1.

Story Continues Below Advertisement

EXPERIENCE THE DIFFERENCE

NEW CXDI-710C and CXDI-810C Wireless Digital Radiography Systems. NEW CXDI Control Software NE Version 2.16 for Windows® 7 and 10. Click for more information>>>



Gen-Probe, based in San Diego, makes tests for STDs and the West Nile Virus, among other conditions.

Gen-Probe's shareholders voted to approve the transaction on Tuesday. Shareholders will receive $82.75 in cash for each share.

Hologic expects the deal to add 20 cents to its adjusted earnings per share for the next fiscal year. The Bedford, Mass.-based company also hopes to realize $75 million in "cost synergies" over the next three years.

This week, while announcing third quarter financial results, Hologic also revealed that it was nearly halfway to its sales goal for its 3-D mammography system, the first of its kind cleared for sale in the United States.

Related:


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED